Smartleaf Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.9K Hold
771
﹤0.01% 1496
2026
Q1
$72.7K Sell
771
-423
-35% -$55.2K ﹤0.01% 1266
2025
Q4
$146K Buy
1,194
+515
+76% +$64.6K 0.01% 976
2025
Q3
$76.5K Buy
679
+131
+24% +$15.3K ﹤0.01% 1213
2025
Q2
$72K Buy
548
+108
+25% +$11.9K 0.01% 1003
2025
Q1
$30.2K Buy
440
+135
+44% +$9.29K ﹤0.01% 1403
2024
Q4
$18.1K Buy
305
+248
+435% +$23.1K ﹤0.01% 1699
2024
Q3
$9.07K Buy
57
+50
+714% +$7.7K ﹤0.01% 1814
2024
Q2
$1.03K Buy
+7
New +$840 ﹤0.01% 2413

Other funds holding TMDX

Smartleaf Asset Management's TMDX Position: Q2 2026 in Review

Smartleaf Asset Management held its Transmedics (TMDX) position steady in Q2 2026 at 771 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Smartleaf Asset Management first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $146K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Smartleaf Asset Management held 771 shares of Transmedics worth $51.9K as of Q2 2026.
  • Smartleaf Asset Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1496 holding.
  • Smartleaf Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Transmedics position peaked at $146K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.